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A B S T R A C T
Purpose: To track the use of medicine and self-medication from infancy to adolescence.
Methods: All newborns in the city of Pelotas, Brazil, were monitored and enrolled in the 1993
Pelotas (Brazil) Birth Cohort Study. Subsamples of the cohort were visited at 1, 3, and 6months and
at 1 and 4 years of age. At 11 and 15 years of age, all cohort members were sought. In each of these
visits, information on medicine use in the 15 days before the interview was collected. Two out-
comes were analyzed: prevalence of medicine use and prevalence of self-medication.
Results: Prevalence ofmedicine use in the ﬁrst year of life ranged from 52.0% to 68.6%. From 4 to 15
years of age, the prevalence decreased, ranging from30.9% to 37.2%. At age 15, girls presented a 33%
higher prevalence of medicine use than boys. The proportion of self-medication ranged from 12.4%
to 29.0% and was higher in girls aged 11 and 15 years than boys of the same age. In all follow-up
periods, use of medicines was signiﬁcantly higher among children who used medicines in the
earlier period. Prevalence of self-medication was higher among those who were self-medicated in
the previous periods.
Conclusions: Tracking studies are important to public health because they can predict future
behavior by analyzing past behavior, thus helping in designing preventive actions. In this study,
previous use of medicines predicts future use, thus creating an opportunity to plan actions that
promote the rational use of medicines.
IMPLICATIONS AND
CONTRIBUTION
In all waves of data collec-
tion of this Brazilian study,
which followed up 4,000
individuals from birth to
adolescence, use of medi-
cines and self-medication
tracked strongly from one
period to the next one, thus
suggesting that preventive
strategies should start as
early as possible. 2012 Society for Adolescent Health and Medicine.
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Open access under CC BY license.Rational use of medicines is of concern, independent of age,
nd becomes even more important in younger ages because
here are signiﬁcant biological differences between children and
dults regarding pharmacokinetics and pharmacodynamics of
edicines [1].
The international literature shows thatmedicine use is highly
revalent among children [2], especially in theﬁrstmonths of life
3], and adolescents [4,5]. The same can be observed in Brazil.
ccording toMoraes et al [6], in the city ofMaringÂ, Brazil, 56% of
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sity of Pelotas, Rua Marechal Deodoro, 1160 3 piso, 96.020-220 Pelotas, Riot
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Open access under CC BYhe adolescents aged 14–18 years had used medicines in the
revious 15 days; 53% used these medicines by self-medication,
nd themajority of these adolescents did not know the names of
heir medicines. Studies carried out in the city of Pelotas, Brazil,
howed a high prevalence of medicine use among children and
dolescents; 64% in children aged 1 year [7], 56% in those aged
–4 years [8], and 31% in those aged 11 years [9]. Consistently,
he literature indicates that the prevalence is higher among girls
han boys [5,6,10,11].
Worldwide, self-medication is an important public health
roblem among children and adolescents [3,12]. The prevalence
f self-medication among children aged 0–17 years was studied
n Germany [13]. It was found that 25.2% of participants had
elf-medicated in the previous week, corresponding to 38.5% of
otal medicine use, including all pharmacological classes. Hol-
 license.
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A.D. Bertoldi et al. / Journal of Adolescent Health 51 (2012) S11–S15S12stein et al [14] described the self-reported medicine use for
common health complaints among those aged 11–15 years in
Denmark between 1988 and 1998, ﬁnding a high proportion of
medicine use, and concluded that the proportion of users in-
creased during the 10 years studied. Studies conducted in Brazil
found that approximately one-half of medication use in adoles-
cents is by self-medication [11,12,14]. Also, it was observed that
self-medication increased according to age from11% at 3months
to 34% at 2 years [7]. Among those aged 7–18 years, the risk of
self-medication was twofold higher compared with children
aged 7 years (odds ratio [OR]  2.81; 95% conﬁdence interval
CI]: 2.09–3.77) [12].
Analyses targeted to observe the likelihood ofmedicine use in
ertain period of life in relation to medicine use in previous
eriods (tracking of medicine use) were not found in the litera-
ure. Tracking is deﬁned as the stability of a variable over a period
15,16]. Malina [17] deﬁned the tracking effect as “individual
rend in maintaining oneself in a determined position or group
fter a period of time.” There are several studies in the literature
hat track other variables, such as food intake [18–20] and phys-
cal activity practice along one’s life [21]. In the area of phar-
acoepidemiology, however, most cohort studies used cross-
ectional approaches to evaluate medicine use [2,3,9,14], and
ust a few used repeated cross-sectional designs to evaluate the
se of speciﬁc groups ofmedicines over time [22–25]. The aim of
his study was to track the use of medicine and self-medication
ractices from infancy to adolescence in a Southern Brazilian
ity.
ethods
All hospital births in the city of Pelotas, Brazil, in 1993 were
onitored. Information was collected using a questionnaire ad-
inistered by trained interviewers to mothers. In total, 5,265
others gave birth in that calendar year in the city, of which
,249 agreed to take part in the cohort study. Newborns were
eighed andmeasured. Subsamples of the cohortwere visited at
, 3, and 6 months and at 1 and 4 years of age. In each of these
isits, information on medicine use by the infant/child in the 15
ays before the interviewwas collected frommothers. At 11 and
5 years of age, all cohort members were searched for follow-up
isits; again, data regarding medicine use in the 15 days before
he interview were collected from mothers. For reported medi-
ine use, mothers were asked for the name of the medicine, the
eason for its use, and whether it had been prescribed by a
hysician. The sample size of each visit is presented in Table 1.
he methodological details of the 1993 Birth Cohort Study are
escribed elsewhere [26].
Table 1
Medicine use and self-medication among boys and girls 15 days before the inter
Study
Follow-up visit Na Medicine use
All (%) Boys (%) Girls (
1 month 649 64.7 67.4 61.9
3 months 644 68.6 69.9 67.3
6 months 1,413 56.6 54.6 58.4
1 year 1,362 52.0 53.5 50.6
4 years 1,272 35.0 37.4 32.7
11 years 4,426 30.9 30.2 31.6
15 years 4,341 37.2 31.9 42.3a Only the 11- and 15-year follow-up studies included the entire sample.For this study, we analyzed two outcomes in each of the
ollow-up visits: (a) prevalence of medicine use and (b) preva-
ence of self-medication. Self-medication refers to the use of any
edicine without a medical prescription. In terms of confound-
rs, we adjusted our analyses for sex, maternal schooling, and
amily income. For analyses using adolescent data, confounders
ere maternal schooling and family’s assets index collected in
dolescence.
We carried out descriptive, crude, and multivariate analyses
sing Stata 10.0 (Stata Corp., College Station, TX). Analyses using
ariables collected at 1 and 4 years of agewereweighed owing to
he oversampling of low-birth-weight children. The descriptive
nalysis included calculating absolute numbers and percentages
or all outcomes, for the whole sample, and separately for boys
nd girls. As themain objectivewas to show tracking ofmedicine
se and self-medication, we also presented the prevalence of the
utcomes according to the same variable in the previous visit. In
hese cases, the medicine use at 11 years of age, for example, is
oth an outcome (themain exposure ismedicine use at 4 years of
ge) and an exposure (the outcome ismedicine use at 15 years of
ge).
In the crude analysis, the prevalence of each outcome was re-
ressed using information on medicine use (or self-medication) in
hepreviousvisit as themainexposure.Theseanalyseswerecarried
ut using logistic regression model, and ORs and 95% CIs are pro-
ided. For the adjusted analyses, the following variables were
dded to themodel: sex, maternal schooling, and family income or
ssets index. Statistical signiﬁcancewas testedusing the 2 test and
was set at 5% (all tests were two-tailed).
The studywas approved by the Research Ethics Committee of
the School of Medicine of the Federal University of Pelotas. Par-
ents or guardians provided written informed consent, authoriz-
ing the participation of their child in the study.
Results
Table 1 shows the prevalence of medicine use in children
from the 1993 Birth Cohort Study. In the ﬁrst year of life, the
prevalencewas higher (ranging from52.0% to 68.6%) than from4
to 15 years of age, in which the prevalence decreased (range:
30.9%–37.2%). Up to age 11, differences in medicine use by sex
were not found. At age 15, girls presented a 33% higher preva-
lence in the use of medicine than boys.
The prevalence of self-medication presented a U-shaped re-
lationship with age. Prevalence values were higher in early life
(up to 3 months of age) and at mid-adolescence (15 of age) as
compared with late infancy (6 and 12months of age), mid child-
hood (4 of age), and early adolescence (11 years of age). Self-
n infancy, childhood, and adolescence—1993 Pelotas (Brazil) Birth Cohort
Self-medication
p All (%) Boys (%) Girls (%) p
.146 29.0 30.5 27.3 .364
.482 25.9 24.4 27.6 .359
.147 15.1 13.9 16.9 .044
.300 17.0 15.8 18.1 .235
.079 15.7 15.4 16.0 .787
.326 12.4 10.3 14.5 .001
.001 20.2 17.3 22.9 .001view i
%)
15 ye
A.D. Bertoldi et al. / Journal of Adolescent Health 51 (2012) S11–S15 S13medication tended to be higher among girls than boys in most
visits, although differences were only statistically signiﬁcant in
adolescence (11- and 15-year follow-ups).
Table 2 shows theprevalence ofmedicineuse according to the
frequency of medicine use in the previous follow-up visit. In all
studied periods, the prevalence of medicine use was higher
among children who used medicines in the earlier period. Con-
sidering medicine use in children aged 1 month, 74.6% of them
also usedmedicines at 3months,whereas 57.5% of thosewhodid
not use medicines at the ﬁrst month of life, used them at 3
months. The same interpretation is applied to the other periods.
Crude and adjusted ORs are also shown in Table 2, indicating the
increased chance ofmedicine use in the current study in relation
to the previous study. All p values were signiﬁcant, indicating
that previous use of medicine predicts use in the future. In the
adjusted model, children who used medicines in the ﬁrst month
of life presented a 2.11 times higher likelihood of using medi-
cines at 3months of age than thosewho did not use at 1month of
age (OR: 2.11; 95% CI: 1.49–2.99).
Similarly, Table 3 shows the same analyses using self-
medication as the outcome. Prevalence of self-medication was
higher among those who were self-medicated in the previous
periods than those who did not self-medicate. However, in
two follow-up visits (1 and 11 years of age), the difference was
not statistically signiﬁcant.
Discussion
The purpose of evaluating tracking of medicine use from
childhood to adolescence is to identify the increased risk of
Table 2
Tracking of medicine use from 1 month to 15 years of age—1993 Pelotas (Brazil)
Follow-up visit Medicine use in the
previous follow-up visit
Unadj
No (%) Yes (%) OR (95
3 monthsc 57.5 74.6 2.17 (1
6 months 49.5 62.5 1.70 (1
1 year 44.4 57.8 1.72 (1
4 years 30.1 39.5 1.52 (1
11 years 29.1 37.4 1.45 (1
15 years 32.4 47.8 1.91 (1
CI  conﬁdence interval; OR odds ratio.
a Unadjusted: In these analyses, medicine use in each study was compared w
medicines at the ﬁrst month of life had a chance to use medicine 2.17-fold h
b Adjusted: Analyses adjusted for sex,maternal schooling, and family incomeat
visits, analyses were adjusted for sex (perinatal data), maternal education at
c The 3-month study was compared with the 1-month study.
Table 3
Tracking of self-medication from 1 month to 15 years of age—1993 Pelotas (Braz
Follow-up visit Self-medication in the
previous follow-up visit
Unadj
No (%) Yes (%) OR (95
3 monthsc 20.5 39.3 2.50 (
6 months 13.1 29.8 2.82 (
1 year 16.4 21.3 1.38 (
4 years 14.7 21.0 1.54 (
11 years 13.0 17.7 1.44 (
15 years 19.1 28.2 1.67 (
a Unadjusted: In these analyses, self-medication in each study was compared
b Adjusted: Analyses adjusted for sex, maternal education, and family incom
follow-up visits, analyses were adjusted for sex (perinatal data), maternal educatio
c The 3-month study was compared with the 1-month study.overmedication and to carry out preventive action aimed at
increasing the rational use ofmedicines during this developmen-
tal period in life. Considering that adolescence is a developmen-
tal stage with special concerns related to behaviors and needs
regarding health care, it is important to understandmedicine use
in this period. Longitudinal analyses carried out using data from
birth cohort studies are the ideal source of information on this
issue.
In the present study, those who used medicines in the previ-
ous period were consistently more likely to use medicines in the
following visits, regardless of age, income, and maternal educa-
tion. The proportion of medicine use among those who had
previously used medicines was higher than among those who
did not use medicines before, thus one of the most important
contributions of this article was to demonstrate that there is a
tracking ofmedicine use from childhood to adolescence. A track-
ing effect was also observed in the practice of self-medication;
those who self-medicated in the past were more likely to con-
tinue to do so.
Cohort studies conducted with children and adolescents in
the northern region of the Netherlands in 1998 [27], in Denmark
between 1988 and 1998 [14], and in the city of Pelotas, Brazil [9],
assessed the prevalence of medicine use at different ages. How-
ever, these studies used cross-sectional analyses, and therefore
did not track the use of medicine over time.
The prevalence of medicine use was higher in the ﬁrst year of
life and decreased with age until the beginning of adolescence,
where a small increase was observed, as found in previous inter-
national [27] and national studies [28]. In a cohort study per-
formed in the northern region of the Netherlands, Schirm et al
Cohort Study
Adjustedb
p OR (95% CI) p
.07) .001 2.11 (1.49–2.99) .001
.39) .002 1.80 (1.28–2.55) .001
.14) .001 1.73 (1.39–2.16) .001
.92) .001 1.45 (1.15–1.84) .002
.88) .004 1.39 (1.06–1.84) .017
.18) .001 1.92 (1.68–2.22) .001
dicine use in the previous period. For example, at 3 months, children who used
than children who did not use medicine at the ﬁrst month.
meof the birth to studies from3months to 4 years. For 11- and15-year follow-up
ars and asset index at 11 and 15 years.
th Cohort Study
a Adjustedb
p OR (95% CI) p
.63) .001 2.34 (1.60–3.42) .001
.34) .001 3.02 (1.94–4.72) .001
01) .086 1.40 (.97–2.04) .075
.23) .024 1.50 (1.03–2.19) .035
19) .088 1.40 (.90–2.19) .140
.05) .001 1.62 (1.31–2.02) .001
elf-medication in the previous period.
he time of the birth to studies from 3 months to 4 years. For 11- and 15-yearBirth
usteda
% CI)
.54–3
.21–2
.38–2
.20–1
.13–1
.67–2
ith me
igher
the tiil) Bir
usted
% CI)
1.75–3
1.83–4
.95–2.
1.06–2
.95–2.
1.35–2
with s
e at tn at 15 years and asset index at 11 and 15 years.
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aged 1 year was 87%; this prevalence decreased to 51% until 12
years of age, remained stable at around 50% from 6 to 12 years of
age, and increased to 64% at 16 years of age.
Bertoldi et al [28] conducted a study in Southern Brazil that
included individuals between 0 and 19 years of age living in an
area covered by the Family Health Program (Programa de SaÛde
da FamÎlia, PSF). Results of this study found the prevalence of
medicine use to be higher in those aged 0–4 years (50.6%), to
decrease in children aged 5–9 years (35.2%), and to increase
again in those aged 10–19 years (38.7%).
The present study is consistent with the national [6,11] and
international [4,5,10] literature regarding the increased use of
medicine during adolescence, in which there is evidence of dif-
ferences by sex in adolescents, with girls having a higher preva-
lence of medicines use than boys [4–6,10,11].
The prevalence of medicines used at 15 years of age was
higher than the prevalence at 11 years of age; these prevalence
rates are lower than those found in other studies (40%–56%)with
teenagers [4–6,10,11]. The trend of increasing use with age dur-
ing adolescence is similar to ﬁndings from other studies. How-
ever, to make comparisons between studies, considerations
must be given to the variability in the recall period and the ages
of the participants in each study.
Holstein et al [5] conducted research with students aged
11–13 years in six European countries and asked aboutmedicine
use for headaches in the past month. The results indicate that
42.5% of the sample hadusedmedicines for headaches during the
past month, and this prevalence increased with age and in girls.
Gobina et al [10] studied adolescents aged 11–15 years and
medicines used by them for headaches, stomachaches, inability
to sleep, and nervousness for a period of 1month in 19 countries
in Europe and in the United States. On average, the most preva-
lent use of medicine was for headaches (40.9%), followed by
stomachaches (23.8%). This study also reported increased medi-
cine use according to age and higher prevalence in girls, for all
medicines examined.
De Moraes et al [6] evaluated the prevalence of medicine use
in the past 15days amonghigh school students (14–18 years old)
living in an urban area in Southern Brazil in 2007. This study
found 55.8% of adolescents took medicine, and the rate was also
higher in girls (girls  64.3%, boys  45.7%, p  .001). Age
presented a positive and signiﬁcant linear trend (p .0001),with
the prevalence rate increasing from50% in those aged 14 years to
57.6% in those aged 16 years.
Furthermore, a study conductedwith a representative sample
of schoolchildren aged 14–16 years, in Porto Alegre, Southern
Brazil, found the consumption ofmedicine in the past 7 dayswas
49.5%, with a signiﬁcantly higher proportion of girls using med-
icine than boys (57.6% vs. 38.8%, p  .001). The same type of
upward trend according to age was also observed in this study
[11].
As for self-medication, the data conﬁrm that this is a fairly
common practice among children and adolescents. The preva-
lence of self-medication was higher in the ﬁrst 3 months of life,
decreasing to values around 15% until 11 years of age, and at 15
years of age, there was an increase, driven primarily by an in-
crease in self-medication in girls. The difference between sexes
in self-medication was evident and has been demonstrated by
other authors [4,13,29]. In a study by Hansen et al [4], at 11 and
15 years of age, a statistical signiﬁcant difference was shown
among girls and boys in self-medication. Yong Du and HildtraudKnopf [13] studied self-medication during the previous week
among children and adolescents from 0 to 17 years of age in
Germany. The authors found that 25.2% of participants had used
self-medication. As in the present study, overall, girls showed a
signiﬁcantly higher level of self-medication than boys, and self-
medication increased from 14 to 17 years of age.
The increased use ofmedicines and self-medication by girls at
15 and 11 years of age, respectively, may be explained by men-
arche, a period in which girls use analgesics and contraceptives.
Hansen et al [4] showed that for girls aged 11–15 years, use of
medicines for headaches and stomachaches occurredmore often
than among boys [4]. Dysmenorrhea is associated with younger
age [30], and dysmenorrheal women use numerous drugs by
self-medication for pain but infrequently accessed formal medi-
cal care [31]. Another explanation is that women typically pres-
ent greater readiness to acknowledge and express their health
needs as compared with men, thus also presenting higher use of
medical care [32]. The study by Klein et al reinforces this idea by
showing that the proportion of girls who reported using a phy-
sician’s ofﬁce was signiﬁcantly higher than boys [33]. According
to Marcell et al, in younger adolescents (11–15 years old), there
are nodifferences between the sexes regardinghealth care visits;
however, in older male subjects, these visits are signiﬁcantly
reduced in comparison with female subjects [32].
In a study by Abahussain et al [34], performed in Kuwait, the
prevalence of self-medication among adolescents aged 14–19
years was high (92%), increasingwith age from 87% among those
aged 14 years to 95% among those aged 18 years; 65% of medi-
cines used were for pain relief. In Brazil, studies show that the
prevalence of self-medication in adolescents is approximately
30% [12,35]. In a study by Silva et al [35], conducted in Fortaleza,
CearÂ, Brazil, with adolescents aged 13–18 years, 34% reported
ever having used medicines because of media advertisements.
According to Silva et al [35], teenagers are in a phase of life in
which they are formulating views on various social factors, in-
cluding the use of medicine and other substances. The authors
point out the widespread practice of self-medication in adoles-
cence, particularly among girls, envisioning possible permanent
medicine users.
Usually in childhood, and often in adolescence, the person
who provides the medicine to the child is either the mother or
guardian responsible for them. In a study conducted among
adolescents [11], one predictor of high medication use in chil-
dren and adolescents was maternal education. Lower maternal
educational was associated with greater likelihood of self-
medication. Bertoldi et al [9] found that medicine use was di-
rectly associated with economic status and maternal schooling
and reported 28% higher levels of self-medication in groupswith
more household assets and higher maternal schooling [9]. The
same study reported a positive association between maternal
use of hypnotic drugs and sedatives and adolescent medicine
use.
One of the limitations of tracking studies is how to conduct
the tracking analysis. Tracking is often estimated by correlation
coefﬁcients between two continuous variables collected at dif-
ferent time points or by the proportion of subjects consistently
classiﬁed in a certain “risk” group at a follow-up measurement.
Also, ORs are used to estimate the magnitude of tracking [15]. In
addition to this broader limitation, there are speciﬁc limitations
to the self-report of medicine use and self-medication owing to
the likelihood of recall bias. Another problem is the possibility
that somemothers were unaware of the use of medicines by the
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used in the treatment of sexually transmitted diseases, for exam-
ple.
Tracking studies are important from an epidemiological per-
spective because future behavior may be “predicted” by analyz-
ing thepast, thus aiding in thedesignof preventive actions. In our
study, we showed that both medicine use and self-medication
track over time. In addition to the tracking effect, the prevalence
of medicine use and self-medication was high. Educational pro-
grams about safe and rational use of medicines at school level
targeted to students and their relatives could be a strategy
to prevent abusive use of medicines and irresponsible self-
medication. Future studies will beneﬁt from analyzing tracking
of use of speciﬁc pharmacological groups.
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